Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceutical companies ranked by revenue, at SGD 121.5B, ahead of Eli Lilly (SGD 84.1B) and Merck & Co (SGD 83.9B). Figures as of 18 Nov 2026, 19:55 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonSGD 121.5B
- Median
- SGD 4.1B
- Combined market value
- SGD 6.52T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SGD 121.5B | SGD 849B | SGD 352.67 | 1.90% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | SGD 84.1B | SGD 1.59T | SGD 1,780.83 | 2.47% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | SGD 83.9B | SGD 436.8B | SGD 177.18 | 4.20% down | 51% up | ||
| 4 | PfizerPFE · Health Care | SGD 80.7B | SGD 206.4B | SGD 36.21 | 1.39% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | SGD 78.9B | SGD 650.9B | SGD 368.23 | 2.51% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | SGD 75.8B | SGD 357.2B | SGD 230.31 | 2.04% down | 2% up | ||
| 7 | NovartisNVS · Health Care | SGD 70.3B | SGD 377.6B | SGD 199.92 | 2.60% down | 25% up | ||
| 8 | SanofiSNY · Health Care | SGD 62.4B | SGD 146.2B | SGD 60.89 | 0.68% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | SGD 62.2B | SGD 157.5B | SGD 77.03 | 2.66% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | SGD 59.2B | SGD 224.1B | SGD 50.85 | 3.13% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | SGD 57.2B | SGD 233.5B | SGD 134.83 | 0.17% down | 17% down | ||
| 12 | GSKGSK · Health Care | SGD 55.9B | SGD 125.8B | SGD 62.77 | 1.18% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | SGD 36.4B | SGD 87.7B | SGD 27.45 | 1.66% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 22.3B | SGD 63.4B | SGD 54.37 | 1.10% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SGD 18.5B | SGD 126.2B | SGD 1,219.75 | 1.27% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | SGD 18.4B | SGD 30.5B | SGD 26.57 | 0.73% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SGD 15.5B | SGD 175.8B | SGD 693.30 | 0.61% up | 27% up | ||
| 18 | ZoetisZTS · Health Care | SGD 12.2B | SGD 45B | SGD 110.71 | 2.82% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | SGD 10.8B | SGD 7.4B | SGD 10.86 | 2.43% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | SGD 6.9B | SGD 59.5B | SGD 521.24 | 2.22% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | SGD 6.1B | SGD 17.3B | SGD 34.63 | 3.87% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 5.5B | SGD 20.5B | SGD 318.73 | 2.65% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | SGD 4.8B | SGD 40.8B | SGD 66.12 | 1.35% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SGD 4.8B | SGD 25.7B | SGD 191.55 | 5.11% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 4.6B | SGD 16.1B | SGD 19.34 | 1.39% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SGD 4.2B | SGD 15.3B | SGD 79.07 | 4.77% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | SGD 4.1B | SGD 31.8B | SGD 747.14 | 0.84% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | SGD 3.9B | SGD 9.8B | SGD 28.13 | 3.27% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | SGD 3.1B | SGD 51.4B | SGD 89.42 | 0.93% up | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | SGD 2.2B | SGD 6.5B | SGD 77.52 | 0.43% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | SGD 1.9B | SGD 10.1B | SGD 59.84 | 2.07% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 4B | SGD 20.87 | 0.43% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 1.2B | SGD 12.1B | SGD 519.87 | 4.49% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | SGD 1.2B | SGD 6B | SGD 35.92 | 3.30% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 7.9B | SGD 56.01 | 1.00% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | SGD 1B | SGD 22.9B | SGD 348.97 | 0.24% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | SGD 982.1M | SGD 9.6B | SGD 87.67 | 3.00% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 874M | SGD 9.6B | SGD 122.46 | 0.18% down | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SGD 823.6M | SGD 9.1B | SGD 173.11 | 1.29% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | SGD 795M | SGD 12.8B | SGD 84.78 | 4.81% up | 107% up | ||
| 41 | InsmedINSM · Health Care | SGD 782.2M | SGD 34B | SGD 154.94 | 1.43% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SGD 672.4M | SGD 7.8B | SGD 119.76 | 0.97% up | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | SGD 647.6M | SGD 19.6B | SGD 100.65 | 1.60% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | SGD 633M | SGD 6.3B | SGD 65.17 | 1.13% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | SGD 345.8M | SGD 7.7B | SGD 385.25 | 1.65% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 244.8M | SGD 10.6B | SGD 153.45 | 2.02% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | SGD 113.6M | SGD 9.3B | SGD 66.44 | 0.28% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | SGD 59.4M | SGD 10.6B | SGD 162.49 | 1.04% up | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | SGD 10.7M | SGD 36.1B | SGD 49.80 | 0.26% down | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | SGD 2.6M | SGD 6.2B | SGD 110.16 | 1.82% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | SGD 0 | SGD 12.4B | SGD 130.42 | 7.78% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | SGD 0 | SGD 11.1B | SGD 395.36 | 0.47% up | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2899 SGD). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by revenue?
Johnson & Johnson (SGD 121.5B), Eli Lilly (SGD 84.1B) and Merck & Co (SGD 83.9B) are the top three of the 52 pharmaceutical companies ranked by revenue as of 18 Nov 2026, 19:55 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of SGD 6.52T as of 18 Nov 2026, 19:55 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.